Common Genomic Variants Associated With Variation in Plasma Lipoproteins in Young Aboriginal Canadians
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (6) , 1060-1066
- https://doi.org/10.1161/01.atv.17.6.1060
Abstract
We hypothesized that common genomic variants would be associated with variation in lipoprotein phenotypes in young subjects. We determined genotypes of FABP2 , PON , APOC3 , and APOE in 188 aboriginal Canadians, aged 9 to 17 years. We found that 13 of 32 possible genotype-phenotype associations were significant: (1) the FABP2 codon 54 genotype was associated with variation in plasma triglycerides ( P =.045); (2) the PON codon 192 genotype was associated with variation in plasma total and LDL cholesterol and apoB ( P =.0099, P =.0088, and P =.016, respectively); (3) the APOC3 insulin-response-element genotype was associated with variation in plasma triglycerides, HDL cholesterol, apoA-I, the total cholesterol to HDL cholesterol ratio, and the apoB to apoA-I ratio ( P =.0014, P =.0069, P =.045, P =.0021, and P =.0081, respectively); and (4) the APOE restriction isotype was associated with variation in plasma LDL cholesterol, apoB, the total cholesterol to HDL cholesterol ratio, and the apoB to apoA-I ratio ( P =.025, P =.034, P =.045, and P =.047, respectively). The average young age and relative absence of age-dependent secondary environmental factors could have eased the identification of small genetic effects on lipoprotein phenotypes in this study sample.Keywords
This publication has 26 references indexed in Scilit:
- The pathogenesis of atherosclerosisClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Risk Factors and Atherosclerosis in Youth Autopsy Findings of the Bogalusa Heart StudyThe Lancet Healthy Longevity, 1995
- Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.Journal of Clinical Investigation, 1995
- An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.Journal of Clinical Investigation, 1995
- Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescentsAtherosclerosis, 1994
- Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45European Journal of Biochemistry, 1993
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Interethnic variation of drug metabolismTrends in Pharmacological Sciences, 1991
- Genetic basis of lipoprotein disorders.Journal of Clinical Investigation, 1989
- Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia.Journal of Clinical Investigation, 1985